SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novartis BidCo AG(91.17%),Novartis Pharma AG(91.17%), etc.
SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novartis BidCo AG(89.47%),Novartis Pharma AG(89.47%), etc.
SC TO-T/A: Third party tender offer statement (Amendment)
SD: Specialized disclosure report
SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novartis BidCo AG(79.58%),Novartis Pharma AG(79.58%), etc.
SC TO-T/A: Third party tender offer statement (Amendment)
144: Notice of proposed sale of securities pursuant to Rule 144
SC TO-T/A: Third party tender offer statement (Amendment)
SC TO-T/A: Third party tender offer statement (Amendment)
SC TO-T/A: Third party tender offer statement (Amendment)
SC TO-T/A: Third party tender offer statement (Amendment)
SC TO-T/A: Third party tender offer statement (Amendment)
SC TO-T/A: Third party tender offer statement (Amendment)
SC TO-T/A: Third party tender offer statement (Amendment)
SC TO-T/A: Third party tender offer statement (Amendment)
6-K: Financial Report Q1 2024
SC TO-T/A: Third party tender offer statement (Amendment)
SC 13D: Statement of acquisition of beneficial ownership by individuals-Novartis BidCo AG(11.56%),Novartis Pharma AG(11.56%), etc.
SC TO-T/A: Third party tender offer statement (Amendment)
SC TO-T/A: Third party tender offer statement (Amendment)
No Data